Moyamoya phenomenon in systemic lupus erythematosus

Rheumatology (Oxford). 2011 Oct;50(10):1931. doi: 10.1093/rheumatology/ker248. Epub 2011 Jul 13.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anticoagulants / therapeutic use
  • Carotid Artery, Internal / pathology
  • Cerebral Angiography
  • Cyclophosphamide / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / pathology*
  • Methylprednisolone / therapeutic use
  • Moyamoya Disease / complications
  • Moyamoya Disease / drug therapy
  • Moyamoya Disease / pathology*
  • Pulse Therapy, Drug
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Vasculitis / drug therapy
  • Vasculitis / pathology
  • Young Adult

Substances

  • Anticoagulants
  • Cyclophosphamide
  • Methylprednisolone